Approval · Notice of Compliance 705 · 2002
ARLIDIN: Notice of Compliance 705
Issued November 29, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 705
- Date
- November 29, 2002
- Company
- Erfa Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Sympathomimetic agent for the relief of selected symptoms in patients with organic brain syndrome/peripheral vasodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARLIDIN | 01926713 | Cancelled Post Market |
Medicinal ingredients
- NYLIDRIN HCL 6 MG per TAB